John L. Gainer
Oprichter bij Diffusion Pharmaceuticals LLC
Actieve functies van John L. Gainer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Diffusion Pharmaceuticals LLC
Diffusion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals LLC develops and manufactures pharmaceutical products. The firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia (oxygen deprivation) is known to diminish the effectiveness of current treatments. The company was founded by Matthew W. Hantzmon, John L. Gainer, and David G. Kalergis in February 2001 and is headquartered in Charlottesville, VA. | Directeur/Bestuurslid | 01-02-2001 | - |
Hoofd Techniek/Wetenschap/O&O | 01-02-2001 | - | |
Oprichter | 01-02-2001 | - | |
International Society on Oxygen Transport to Tissue
International Society on Oxygen Transport to Tissue Miscellaneous Commercial ServicesCommercial Services The International Society on Oxygen Transport to Tissue operates a tissue oxygen research laboratory. The non-profit company is based in Washington. | Corporate Officer/Principal | 01-01-1973 | - |
Loopbaan van John L. Gainer
Eerdere bekende functies van John L. Gainer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DIFFUSION PHARMA | Directeur/Bestuurslid | 01-01-2016 | 25-06-2021 |
Hoofd Techniek/Wetenschap/O&O | 01-01-2016 | 12-03-2020 | |
Oprichter | 01-01-2001 | 25-06-2021 | |
Alumni Association of the University of Virginia
Alumni Association of the University of Virginia Miscellaneous Commercial ServicesCommercial Services Alumni Association of the University of Virginia assists and encourages relation between alumni and students. The company was founded on July 4, 1838 and is headquartered in Charlottesville, VA. | Corporate Officer/Principal | 01-01-1966 | - |
University of Virginia | Corporate Officer/Principal | 01-01-1966 | 01-01-2005 |
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Directeur/Bestuurslid | 08-01-2016 | - |
Hoofd Techniek/Wetenschap/O&O | 08-01-2016 | - |
Opleiding van John L. Gainer
Massachusetts Institute of Technology | Graduate Degree |
University of Delaware | Doctorate Degree |
West Virginia University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Operationeel
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Sectoraal
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Diffusion Pharmaceuticals LLC
Diffusion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals LLC develops and manufactures pharmaceutical products. The firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia (oxygen deprivation) is known to diminish the effectiveness of current treatments. The company was founded by Matthew W. Hantzmon, John L. Gainer, and David G. Kalergis in February 2001 and is headquartered in Charlottesville, VA. | Health Technology |
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Health Technology |
Diffusion Pharmaceuticals, Inc.
Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |
International Society on Oxygen Transport to Tissue
International Society on Oxygen Transport to Tissue Miscellaneous Commercial ServicesCommercial Services The International Society on Oxygen Transport to Tissue operates a tissue oxygen research laboratory. The non-profit company is based in Washington. | Commercial Services |
Alumni Association of the University of Virginia
Alumni Association of the University of Virginia Miscellaneous Commercial ServicesCommercial Services Alumni Association of the University of Virginia assists and encourages relation between alumni and students. The company was founded on July 4, 1838 and is headquartered in Charlottesville, VA. | Commercial Services |
- Beurs
- Insiders
- John L. Gainer
- Ervaring